Viewing Study NCT01650350


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-02 @ 9:43 AM
Study NCT ID: NCT01650350
Status: TERMINATED
Last Update Posted: 2022-03-04
First Post: 2012-07-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
Sponsor: Brown University
Organization: